Your basket is empty
Pharmaceutical giant GlaxoSmithKline is poised to begin developing products based on traditional Chinese medicines as part of its revamped research and development strategy.
Categories: Herb research
If you are already subscribed log into your account now:
Subscribe to the Journal of Chinese Medicine now from only £30.00 per year. Your subscription will include: